Recent experimental and clinical studies have suggested that oxidative stress is enhanced in heart failure. The production of oxygen radicals is increased in the failing heart whereas antioxidant enzymeactivities are preserved. Mitochondrial electron transport is an enzymatic source of oxygenradical generation and also a target against oxidantinduced damage. Chronic increases in oxygen radical production in the mitochondriacan lead to a catastrophic cycle of mitochondrial DNAdamage as well as functional decline, further radical generation, and cellular injury. These cellular events might play an important role in the development and progression of myocardial remodeling and failure.
Introduction
Congestive heart failure (HF) is an important cause of morbidity and mortality in patients with various heart diseases. Despite extensive studies, the fundamental mechanismsresponsible for the development and progression of left ventricular (LV) failure have not yet been fully elucidated. Reactive oxygen species (ROS) such as superoxide anions ( O2~) and hydroxy radicals ( OH) cause the oxidation of membrane phospholipids, proteins, and DNAs( 1) and have been implicated in a wide range of pathological conditions including ischemiareperfusion injury, neurodegenerative diseases, and aging. Under physiological conditions, their toxic effects can be prevented by such scavenging enzymes as superoxide dismutase (SOD) , glutathione peroxidase (GSHPx), and catalase as well as by other non-enzymatic antioxidants. However, when the production of ROSbecomesexcessive, oxidative stress might have a harmful effect on the functional and structural integrity of biological tissue. ROScause contractile failure and structural damagein the myocardium. The importance of oxidative stress is increasingly emerging with respect to LVdysfunction and HF progression.
Oxidant Stress in Failing Hearts
Recent experimental and clinical investigations have suggested the generation of ROSto increase in chronic HF (2) (3) (4) (5) . Lipid peroxides and 8-iso-prostaglandin F2a, which are the major biochemical consequences of ROSgeneration, have been shown to be elevated in plasma and pericardial fluid of patients with HFand also positively correlated to the severity of HF (2, 3) . However, all of these findings have provided only indirect evidence of ROS generation in the failing hearts. It is difficult to quantify the amount of ROSin the intact biological system since they are unstable and rapidly react with unoxidized adjacent molecules and thus their half life is very short. The only method to directly quantify ROSin biological tissue is electron spin resonance (ESR) spectroscopy. Using ESR combined with the nitroxide radical, 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-N-oxyl (hydroxy-TEMPO), as a spin probe, we first provided a definitive and direct demonstration of enhanced generation of ROSin the failing myocardium (6) . O2~is a primary radical that could lead to the formation of other ROS, such as H2O2and -OH, in the failing myocardium. -OH could arise from electron exchange between O2~and H2O2via the Harber-Weiss reaction. In addition, -OHis also generated by the reduction of H2O2in the presence of endogenous iron by means of the Fenton reaction. The generation of -OHimplies a pathophysiological significance of ROSin HF since -OH radicals are the predominant oxidant species causing cellular injury.
The decreased antioxidant capacity could further aggravate the ROSaccumulation in HF. However, there is no significant difference in the total SODand catalase content between control and HF (7) . GSHPx activity is even higher in failing hearts. These results thus indicate that oxidative stress in HFis primarily due to the enhancement of prooxidant generation rather than to the decline in antioxidant defenses. Moreover, the generation of ROSis greater than the scavenging capacity of endogenousantioxidants within the failing myocardium. tides involved in oxidative phosphorylation, including 7 subunits (ND1, ND2, ND3, ND4, ND4L, ND5, and ND6) ofrotenone-sensitive NADH-ubiquinone oxidoreductase (complex I), 1 subunit (cytochrome b) of ubiquinol-cytochrome c oxidoreductase (complex III) , 3 subunits (COI, COII, and COIII) of cytochrome-c oxidase (complex IV), and 2 subunits (ATPases 6 and 8) of complex V along with 22 tRNAs and 2 rRNA (12S and 16S) subunits. The polypeptides are translated by mitochondrial ribosomes and consist of components of the electron transport chain (Fig. 2) . The mtDNA could be a major target for ROS-mediateddamage for several reasons. First, mitochondria do not have a complex chromatin organization consisting of histone proteins, which mayserve as a protective barrier against ROS.Second, mtDNAhas a limited repair activity against DNAdamage. Third, a large part of O2~which is formed inside the mitochondria can not pass through the membranesand, hence, ROS damagemaybe contained largely within the mitochondria. In fact, mtDNAaccumulates significantly higher levels of the DNAoxidation product, 8-hydroxydeoxyguanosine, than nuclear DNA(1 1). As opposed to nuclear-encoded genes, mitochondrial-encoded gene expression is largely regulated by the copy number of mtDNA (12) . Therefore, mitochondrial injury is reflected by mtDNAdamage as well as by a decline in the mitochondrial RNA(mtRNA) transcripts, protein synthesis, and mitochondrial function (13, 14) . Wehave recently shown that the increased generation of ROSwas associated with mitochondrial damage and a dysfunction in the failing hearts, which were characterized by an increased lipid peroxidation in the mitochondria, a decreased mtDNAcopy number, a decrease in the numberof mtRNA transcripts, and a reduced oxidative capacity due to low complex enzyme activities (15) . Chronic increases in ROSproduction are associated with mitochondrial damage and dysfunction which thus can lead to a catastrophic cycle of mitochondrial functional decline, further ROS generation, and cellular injury (Fig. 3 ). MtDNAdefects may thus play an important role in the development and progression of myocardial remodeling and failure. A number of pathogenic mtDNA base substitution mutations, such as missense mutations and mtDNA rearrangement mutations (deletions and insertions), have been identified in patients with mitochondrial diseases ( 16) . An accumulation of the deleted forms of mtDNAin the myocardiumfrequently results in either cardiac hypertrophy, conduction block, or HF (17) . Furthermore, there is nowa consensusview that mutations in mtDNAand abnormalities in mitochondrial function are associated with commonforms of cardiac diseases such as ischemic heart disease (18) and dilated cardiomyopathy (19) . In these conditions, however, the strict causal relationships between abnormalities in mtDNAand cardiac dysfunction have yet to be fully elucidated (20) . Even though the mechanisms by which mtDNA damagearises in these conditions have not been clarified, ROShave been proposed to be the primary contributing factor. Wehave provided direct evidence that mtDNA defects occur not only in a limited small subset of mitochondrial diseases but also in a more commonHFphenotype occurring after myocardial infarction. This is further supported by the studies on mice lacking MnSOD which show an accumulation of oxidative damageof mtDNAs and electron transport complexes (21) in association with the development of dilated cardiomyopathy (22) .
Oxidative Stress and Myocardial Damage
ROShave direct effects on cellular structure and function and may be integral signaling molecules in myocardial remodeling and failure (Fig. 4) . ROSresult in a phenotype characterized by hypertrophy and apoptosis in isolated cardiac myocytes (23) . ROShave also been shown to activate matrix metalloproteinase (MMP)in cardiac fibroblasts (24) . Myocardial MMP activity is increased in the failing hearts. Further, an MMP inhibitor has been shown to limit early LVdilatation in a murine model of myocardial infarction (25) . Because MMPcan be activated by ROS,one proposed mechanism of LV remodeling is the activation of MMPsecondary to increased ROS production. Sustained MMPactivation might therefore influence the structural properties of the myocardium by providing an abnormal extracellular environment with which the myocytes interact. We have demonstrated that -OH scavenger, dimethylthiourea, inhibits the activation of MMP in association with the development of LVremodeling and failure (26) . These data raise the interesting possibility that increased ROSafter myocardial infarction can be a stimulus for myocardial MMP activation, which might play an important role in the development of HE Oxidative Stress and Skeletal Muscle Dysfunction Oxidative stress could be the mechanistic basis for muscle fatigue and reduced exercise tolerance in HF patients (27) . This notion is supported by a positive correlation between ROSand exercise intolerance in these patients (28) . The production of ROSwas increased in the skeletal muscle homogenates obtained from a murine model of HFand increased ROSwere identified as -OH originating from O2~, which was associated with a concomitant increase in the oxidation of lipids (29) . These results are consistent with the previous studies that the oxidative capacity is reduced and O2 utilization is inadequate in skeletal muscle mitochondria from HF patients (30) . Skeletal muscle mitochondria from HFare associated with a decrease in the complex I and III activities (29) . As has been shown in the failing hearts (8) , the defects in electron transfer function may lead to the ROS production. ROS may play an important role in the muscle atrophy commonlyseen in HF patients through the induction of apoptosis. In addition, ROS impair myoplasmicCa2+homeostasis and inhibit the oxidative energy production in the mitochondria, both of which may con-tribute to the muscle contractile dysfunction. Anattempt to attenuate oxidative stress would improve, to someextent, the exercise capacity of patients with HF.
Future Perspectives
What is stimulating oxidative stress in HF? Several possible factors might be involved as the stimuli for increased ROSin HF. The activation of neurohumoral factors commonlyseen in HF, including catecholamines and cardiac sympathetic tone, renin-angiotensin system, cytokines, and nitric oxide, can all contribute to the generation of ROS.If mitochondria are the principle source of ROSin response to cytokines such as TNFa and NO, such stimuli may directly modify mitochondrial electron transport function and lead to superoxide production. This would further imply that chronic remodeling stimuli alter the level of myocardial oxidative stress. In addition, angiotensin II and cytokines can stimulate activity and/or expression of NAD(P)H oxidase (3 1). Catecholamines can also contribute to the generation of ROSby the enhanced autooxidation. Further investigation on this issue is extremely important and may provide further insight into the pathophysiology of HF (9) . Recent studies from our laboratory and those from others have demonstrated that oxidative stress is involved in certain cardiovascular disease states, including atherosclerosis, hypertension, and nowheart failure. ROSmay contribute to the functional and structural changes that lead to disease progression. Therapeuticstrategies to modulatethis maladaptiveresponse should become a target for future research.
Conclusions
Oxidative stress is enhanced in HF. The production of ROS is increased in the failing hearts whereas antioxidant enzyme activities are preserved normal. Mitochondrial electron transport is an enzymatic source of ROSgeneration and also a target against ROS-induced damage. Chronic increases in ROS production in the mitochondria can lead to a catastrophic cycle of mitochondrial functional defects, further ROSgeneration, and cellular injury. These cellular events might play an important role in the development and progression of myocardial remodeling and failure.
